TheStreet.com

Adam Feuerstein, senior biotech writer at the TheStreet.com, tweeted that he thinks that Cell Therapeutics, Inc. (NASDAQ: CTIC) may buy Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS). This is all speculation on his part, and there has been no talk of a merger between the companies. Sunesis...

An update on Spherix Incorporated (NASDAQ: SPEX), which was sharply higher this morning on news that it completed a successful Phase 3 test for its diabetes drug. Well, it appears traders aren't buying it, as shares were up around 90% in pre-market trading, and are now down 18% in a dramatic...

TheStreet.com has an interesting article out today about three bank stocks that investors should be keeping an eye on as we head into earnings season. According to Peter Kovalski, the key issue for the banking sector as a whole will be bringing down problem assets. He said, "The focus will be...

TheStreet.com's senior biotech columnist Adam Feuerstein had a live blog today, in which he discussed the Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) ruling from the FDA on its weight loss drug, lorcaserin. The blog had more 5,000 readers, and almost 350,000 page views, an unprecedented number of...

NEW YORK (TheStreet) -- A roster of stocks hit fresh 52-week highs on Monday. By market cap, the largest companies to reach fresh heights were blue chips Siemens (NYSE: SI), McDonald's (NYSE: MCD), AstraZeneca (NYSE: AZN), Altria Group (NYSE: MO) and Deere (NYSE: DE). Which will outperform in the...

NEW YORK (TheStreet) -- Oil futures were holding higher Monday alongside equities as traders awaited Tuesday's meeting of the Federal Open Market Committee. The September crude oil delivery contract was advancing 39 cents to $81.09 a barrel. Phil Flynn, energy analyst at PFGBest, said the market...

In an article on TheStreet.com and also in a tweet, Doug Kass, president of Seabreeze Partners is saying to short bonds as stocks begin to move towards the upper end of his range for the S&P 500, which is 1150. He believes that by going long ProShares UltraShort 20+ Year Treasury (NYSE: TBT...

NEW YORK (TheStreet) -- One of the benefits of ETF proliferation is access to previously difficult-to-reach market segments for individual investors. To see the new emerging-market ETF, check out check out TheStreet.com.

BOSTON (TheStreet) -- Investors in stocks that trade for less than $5 think of nothing more than a quick return. Some are lucky enough to double their money. Some get wiped out. After all, many large investment firms bar their own managers and traders from holding stocks that cost less than $5....

NEW YORK (TheStreet) -- The concept of a cheap bank stock with good earnings potential may sound like an oxymoron, but there are a few out there these days. Using data provided by SNL Financial, TheStreet has narrowed down the 10 bank stocks trading under $5 with the highest earnings expectations...

BOSTON (TheStreet) -- U.S. stocks are vacillating between the positivity of strong earnings reports and the negativity of soft economic data. Short-sellers are on the prowl, looking to exploit weakness in heavy-volume names. Here are the 10 most shorted S&P 500 stocks. They are ordered by...

NEW YORK (TheStreet) -- Let's be honest, any real surprises within the casino sector in the second-half of the year will almost surely come from Asia. As it stands, the U.S. domestic market appears to have little luck left. Because while the risk for U.S. casino hotels has subsided from its peak...

NEW YORK (TheStreet) -- Although consumer confidence was still in retreat in July, Standard & Poor's Ratings Services says the outlook for U.S. consumer product companies is actually improving due to cost reduction activities. "The pace of downgrades has slowed in the past 12 months, following...